Avior Wealth Management’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,056
Closed -$1.48K 3903
2024
Q1
$1.48K Buy
2,056
+6
+0.3% +$4 ﹤0.01% 2330
2023
Q4
$1.74K Hold
2,050
﹤0.01% 1320
2023
Q3
$2.81K Buy
+2,050
New +$4.44K ﹤0.01% 1338

Other funds holding VAXX

Avior Wealth Management's VAXX Position: Q2 2024 in Review

Avior Wealth Management sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 2,056 shares — an estimated $1.48K sold.

Avior Wealth Management first reported a position in VAXX in Q3 2023 and held it in 3 quarters. The position peaked at $2.81K in Q3 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Avior Wealth Management reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 2,056 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $1.48K.
  • Avior Wealth Management first reported a position in Vaxxinity, Inc. Class A Common Stock in Q3 2023 and held it in 3 quarters.
  • Avior Wealth Management's Vaxxinity, Inc. Class A Common Stock position peaked at $2.81K in Q3 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.